Juan M. S.
- Country
- Spain
- Department
- Servicio de enfermedades infecciosas
Research Overview
- Phase 3 Randomized Non‑Inferior Trial of Ultra‑Long‑Acting Cabotegravir + Rilpivirine vs Long‑Acting Formulations in Adults/Adolescents with Virologically Suppressed HIV
- A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of oral VH4524184 Coadministered with Emtricitabine and Tenofovir Alafenamide in Treatment Naïve Viremic Persons with HIV-1.( INNOVATE Study)
Data & Insights
Has run more than one trial at 14 of 73 partner sites.
Specializations
Infectious Diseases & Pandemic Response
Focus on emerging viral infections, severe bacterial sepsis, and antimicrobial stewardship.
- COVID-19
- Clostridioides difficile infection
- Pseudomonas aeruginosa bacteremia
- Invasive candidiasis
- Enterobacteriaceae infections
Emphasis on clinical evaluation of novel antivirals and antibiotic regimens.
Oncology & Targeted Cancer Therapies
Involvement in solid tumor and hematologic malignancies, especially lung, breast, ovarian, and colorectal cancers.
- Non‑Small Cell Lung Cancer
- Triple‑Negative Breast Cancer
- Advanced Ovarian Cancer
- Metastatic Colorectal Cancer
- Small Cell Lung Cancer
Participation in trials assessing targeted agents and immunotherapies.
Autoimmune & Systemic Inflammatory Disorders
Research on systemic lupus erythematosus, psoriatic arthritis, ulcerative colitis, and related conditions.
- Systemic Lupus Erythematosus
- Psoriatic Arthritis
- Ulcerative Colitis
- Rheumatoid Arthritis
- Multiple Sclerosis
Evaluation of biologic and small‑molecule modulators.
Cardiovascular & Metabolic Disease Management
Studies on atherosclerotic disease, heart failure, dyslipidemia, and hypertension.
- Atherosclerotic Cardiovascular Disease
- Heart Failure with Reduced Ejection Fraction
- Heart Failure with Preserved Ejection Fraction
- Dyslipidemia
- Resistant Hypertension
Integration of cardiovascular outcomes with metabolic risk reduction.
Hematology & Blood Disorders
Focus on lymphoid malignancies, myelodysplastic syndromes, and coagulation abnormalities.
- Chronic Lymphocytic Leukemia
- Diffuse Large B‑Cell Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Thrombocytopenia
Assessment of novel agents and combination regimens in hematologic settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.